Inspire Investing, LLC Precigen, Inc. Transaction History

Inspire Investing, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$1.27 - $2.26 $6,252 - $11,125	-4,923 Reduced 17.02%	24,006 $0
Q3 2022 Nov 07, 2022	BUY	$1.41 - $2.79 $3,890 - $7,697	2,759 Added 10.54%	28,929 $61,000
Q2 2022 Aug 10, 2022	BUY	$1.15 - $2.53 $10,987 - $24,171	9,554 Added 57.5%	26,170 $35,000
Q1 2022 Apr 21, 2022	BUY	$1.91 - $3.98 $10,163 - $21,177	5,321 Added 47.11%	16,616 $35,000
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $39,871 - $62,122	11,295 New	11,295 $42,000
Q4 2020 Feb 12, 2021	SELL	$3.75 - $10.56 $45,678 - $128,631	-12,181 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.5 - $6.2 $3,038 - $5,381	868 Added 7.67%	12,181 $43,000
Q2 2020 Aug 12, 2020	BUY	$2.16 - $5.46 $5,732 - $14,490	2,654 Added 30.65%	11,313 $56,000
Q1 2020 May 08, 2020	BUY	$1.46 - $7.19 $12,642 - $62,258	8,659 New	8,659 $29,000

143

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $354M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.